Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLA.L Regulatory News (SLA)

  • There is currently no data for SLA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results - Part 1 of 8

9 Mar 2021 07:00

RNS Number : 5739R
Standard Life Aberdeen plc
09 March 2021
 

 

 

 

Standard Life Aberdeen plc

Full Year Results 2020

Part 1 of 8

 

 

Full year results 2020 and strategy update

9 March 2021

Positioning for growth

The Standard Life Aberdeen plc Annual report and accounts 2020 (Annual report 2020) has been published today and is available at www.standardlifeaberdeen.com/annualreport 

This summary contains information that has been extracted from the Annual report 2020.

 

Full year results 2020

 

· Fee based revenue of £1,425m (2019: £1,634m), lower than prior year largely reflecting impact of 2019 outflows

· Adjusted operating expenses reduced by 10% to £1,206m (2019: £1,333m) due to cost control initiatives and efficiencies including c£20m of COVID-related savings in discretionary costs

· Adjusted operating profit of £219m (2019: £301m) and adjusted profit before tax of £487m (2019: £584m) largely reflecting lower revenue

· IFRS profit before tax of £838m (2019: £243m) reflecting profit on disposal of interests in associates partially offset by impairments of goodwill and intangibles

· Diluted EPS of 37.9p and adjusted diluted EPS of 18.1p, compared with 8.8p and 19.3p, respectively, in 2019

· Improved investment performance with 66% (2019: 60%) of AUM above benchmark over three years

· Net outflows reduced to £3.1bn (2019: £17.4bn) excluding LBG tranche withdrawals, driven by a significant improvement in Institutional and Wholesale net flows

· AUMA of £534.6bn (2019: £544.6bn) reflecting £25.9bn LBG tranche withdrawals, partially offset by improvements in markets

· Cost/income ratio of 85% (2019: 82%), driven by revenue decline

· Strong surplus capital position of £2.3bn (2019: £1.7bn) benefiting from Indian stake sales

· The Board remains committed to delivering a dividend that is sustainable over the medium term. Reflecting current operating profitability, industry trends, and economic and market uncertainties, the Board is rebasing the dividend to a level from which it can be grown

· Therefore the Board is recommending a final dividend in respect of 2020 of 7.3p per share, bringing the total dividend for the year to 14.6p per share. The Board intends to maintain the total dividend at this level until covered at least 1.5 times by adjusted capital generation, at which point the Board will seek to grow the dividend in line with its assessment of underlying medium term growth in profitability

 

Our new strategic pathway towards growth over the medium term

 

· Our strategy is to deliver client led growth through three growth vectors: Investments, Adviser, and Personal

· We have a clear growth strategy for each vector that will contribute to revenue and earnings growth

· We have identified clear strategic priorities: Growth in Asia, UK adviser and consumer markets, Solutions and Responsible investing

· We have already taken action to simplify and strengthen the business in line with our new strategy:

o We are simplifying the business through the announced exits from Nordics real estate and Indonesia, and the proposed sale of Parmenion

o Strengthening our capabilities is a key objective, demonstrated by our proposed acquisition of Tritax, a specialist logistics real estate business, to augment our private market capabilities

o We have reached agreement on a simplified and enhanced strategic partnership with our largest client, Phoenix, in February 2021

o Our rebranding activity is underway to bring the business under one unifying brand, with further details to come later in the year

 

Outlook

 

· The aim of our new strategy is to return the business to revenue and earnings growth, generating an earnings profile that creates value for shareholders including a sustainable level of dividends

· By focusing on individual growth strategies for each vector we aim to arrest revenue decline in the near term, inflecting to a high single digit three year revenue CAGR over the period to 2023

· Completion of transformation programme drives cost reduction in the near term and positions cost base for future growth

· As we move into revenue growth, expect growth-related increases in certain costs but we will maintain the operating leverage created by the rebalanced cost base

· Targeting to exit 2023 at a cost/income ratio of c70%

· Expect stabilisation of revenue yield in near term, subsequently increasing as we meet client preferences for higher yielding assets

· Disciplined approach to capital allocation with a focus on building returns for shareholders

 

Stephen Bird, Chief Executive Officer, commented:

 

"We have seen growing momentum in the second half of 2020 with improved investment performance and flows which represent an inflection point as we pull out of the post-merger era. We remain on track to deliver targeted synergies and have identified more that we can deliver. We have exited some non-core businesses and made an acquisition that has extended our capabilities in private markets. We have simplified and clarified leadership structures across the business and placed a refreshed focus on Asia.

We have a clear vision; we will focus on the future to enable our clients to be better investors. To do this we will pursue efficient, sustainable growth by ensuring that our product capabilities, technology and performance are first class. Our pursuit of client led growth, combined with focus on efficiency and careful deployment of capital, will enable us to generate sustainable value for our shareholders.

We have three growth vectors - Investments, Adviser and Personal. Thanks to our strong capital position, we have strategic flexibility around how we grow these businesses and we have set out clear ambitions.

At this reset point for this business, we have rebased to set firm foundations on which we can build something great. I'm excited about what's to come."

 

Key indicators for 2020

 

 

2020

2019

Financial indicators

 

 

Fee based revenue

£1,425m

£1,634m

Cost/income ratio

85%

82%

Adjusted operating profit

£219m

£301m

Adjusted profit before tax

£487m

£584m

Adjusted capital generation

£262m

£333m

IFRS profit before tax

£838m

£243m

Adjusted diluted EPS

18.1p

19.3p

Full year DPS

14.6p

21.6p

 

 

 

Business indicators

 

 

Gross inflows

£74.3bn

£86.2bn

Net flows

 

 

Excluding LBG

(£3.1bn)

(£17.4bn)

Total

(£29.0bn)

(£58.4bn)

AUMA

£534.6bn

£544.6bn

Investment performance (AUM) - 3 years

66%

60%

 

Media

 

A conference call for the media will take place on Tuesday 9 March 2021 at 8.00am (GMT). Participants should dial 0800 640 6441 or +44 20 3936 2999 followed by the passcode: 115496.

 

Institutional investors and analysts

 

A presentation for institutional investors and analysts will take place via webcast at 9.45am (GMT) on Tuesday 9 March 2021. To join the webcast please go to www.standardlifeaberdeen.com/investors. There is also the facility to join the presentation and Q&A session via a conference call. Participants should dial +44 (0) 20 3936 2999 and use passcode: 131769.

FOR A PDF VERSION OF THE FULL ANNUAL REPORT AND ACCOUNTS, PLEASE CLICK HERE

http://www.rns-pdf.londonstockexchange.com/rns/5739R_1-2021-3-9.pdf

 

 

For further information please contact:

Institutional equity investors and analysts

Retail equity investors

Catherine Nash

07798 518 657

Link Market Services*

0345 113 0045

Helen Rennardson

07554 010 422

 

 

Media

 

Debt investors and analysts

Andrea Ward

07876 178696

Nick Mardon

07515 298 212

Iain Dey (Edelman Smithfield)

07976 295906

 

Latika Shah (Edelman Smithfield)

07950 671948

 

*Calls may be monitored and/or recorded. Call charges will vary.

 

Note: Unless otherwise stated, all figures in this summary are on a continuing operations basis.

 

Standard Life Aberdeen plc's LEI Code is 0TMBS544NMO7GLCE7H90

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR FZGGFGLZGMZG
Date   Source Headline
2nd Jul 202112:11 pmRNSForm 8.3 - UDG Healthcare plc
2nd Jul 202112:08 pmRNSForm 8.3 - Vectura Group plc
2nd Jul 202111:58 amRNSForm 8.3 - Sanne Group plc
2nd Jul 202111:49 amRNSForm 8.3 - Spire Healthcare Group plc
2nd Jul 202111:49 amRNSForm 8.3 - John Laing Group plc
2nd Jul 202111:44 amRNSForm 8.3 - Equiniti Group plc
2nd Jul 202111:42 amRNSForm 8.3 - Ultra Electronics Holdings plc
2nd Jul 202111:40 amRNSForm 8.3 - St. Modwen Properties plc
2nd Jul 202111:37 amRNSForm 8.3 - Wm Morrison Supermarkets plc
1st Jul 20211:06 pmRNSForm 8.3 - John Laing Group plc
1st Jul 20211:02 pmRNSForm 8.3 - Equiniti Group plc
1st Jul 202112:59 pmRNSForm 8.3 - Ultra Electronics Holdings plc
1st Jul 202112:55 pmRNSForm 8.3 - St. Modwen Properties plc
1st Jul 202112:50 pmRNSForm 8.3 - Wm Morrison Supermarkets plc
1st Jul 202112:36 pmRNSTotal Voting Rights
1st Jul 202111:45 amRNSForm 8.3 - UDG Healthcare PLC
1st Jul 202111:37 amRNSForm 8.3 - Vectura Group plc
1st Jul 202111:34 amRNSForm 8.3 - Sanne Group plc
1st Jul 202111:30 amRNSForm 8.3 - Spire Healthcare Group plc
30th Jun 202111:53 amRNSForm 8.3 - John Laing Group plc
29th Jun 202111:51 amRNSForm 8.3 - Ultra Electronics Holdings plc
29th Jun 202111:46 amRNSForm 8.3 - St. Modwen Properties plc
29th Jun 202111:44 amRNSForm 8.3 - John Laing Group plc
29th Jun 20217:05 amRNSSale of shares in HDFC Life
28th Jun 20213:12 pmRNSForm 8.3 - Ultra Electronics Holdings plc
28th Jun 202110:47 amRNSForm 8.3 - John Laing Group plc
25th Jun 20214:24 pmRNSHolding(s) in Company
25th Jun 202111:50 amRNSForm 8.3 - John Laing Group plc
24th Jun 20215:16 pmRNSHolding(s) in Company
24th Jun 202111:19 amRNSForm 8.3 - John Laing Group plc
24th Jun 202110:19 amRNSHolding(s) in Company
23rd Jun 20212:38 pmRNSForm 8.3 - John Laing Group plc
22nd Jun 202111:55 amRNSForm 8.3 - Wm Morrison Supermarkets plc
21st Jun 20215:34 pmRNSHolding(s) in Company
21st Jun 202112:07 pmRNSForm 8.3 - UDG Healthcare PLC
21st Jun 202111:57 amRNSForm 8.3 - Vectura Group plc
21st Jun 202111:56 amRNSForm 8.3 - Sanne Group plc
21st Jun 202111:55 amRNSForm 8.3 - John Laing Group plc
21st Jun 202111:53 amRNSForm 8.3 - Spire Healthcare Group plc
21st Jun 202111:52 amRNSForm 8.3 - St. Modwen Properties plc
21st Jun 202111:51 amRNSForm 8.3 - Equiniti Group plc
18th Jun 20214:00 pmRNSHolding(s) in Company
18th Jun 202110:35 amRNSForm 8.3 - Sanne Group plc
17th Jun 20214:28 pmRNSHolding(s) in Company
17th Jun 202111:02 amRNSForm 8.3 - John Laing Group plc
17th Jun 202111:00 amRNSForm 8.3 - St. Modwen Properties plc
16th Jun 202112:37 pmRNSForm 8.3 - John Laing Group plc
16th Jun 202112:36 pmRNSForm 8.3 - Spire Healthcare Group plc
16th Jun 202112:34 pmRNSForm 8.3 - Senior plc
16th Jun 202110:20 amRNSForm 8.3 - UDG Healthcare PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.